Founder/CEO of HuBE Health

Dr. Brian Kolender is an expert in Preventive Health and board certified in Internal Medicine. He has been practicing for over 25 years and is continually evolving his practice to include the best possible care for his patients. At his practice, Sante by Kolender, heart attack and stroke are preventable, chronic disease avoidable, and longevity tools are always considered and available.

The Kolender Medical Show went live in June, 2019, and educates listeners in the Midwest and beyond on 50,000W WJR 760 AM. Listeners are able to call in and ask questions live on the air, while Dr. Kolender and his co-host, Annemarie Cronin, discuss timely topics in healthcare with a focus on prevention. The show is evolving to Leading Medicine as we expand beyond the Midwest and expose listeners to more of what they do not know about healthcare.

Recognizing the need and opportunity, Dr. Kolender founded Hube Health LLC to provide prevention services at low cost anywhere in the world. We are happy to announce a partnership with UCIMED in San Jose, Costa Rica. Together we will be performing the world’s first prospective heart attack and stroke prevention study!

Advisor

“An ounce of prevention is worth at least a pound of cure.”- Lauren J. Bear rendition.

Ms. Bear is a researcher, physiologist and nutritionist who is now in her fourth decade of successfully enabling herself and others to make the changes they seek to make in their physical and mental health. Broad as this goal may read, Lauren began work back in the 80’s on the design of a reliable way to assist herself, and those who wanted her help, move beyond specific challenging junctures in life. Today, the tools available for this are improving very rapidly and HuBe is the logical pivot.

The explosion in computing power, data, and non-invasive healthcare innovation is stunning. Many qualitative aspects of the sciences are now/becoming quantifiable and more useful. Importantly: actual 'cause and effect relationship', reproducibly so, is becoming more objectively identifiable than ever, even in historically ‘soft’ sciences. And: Comparatively, humans have not been changing.

To study the ramifications of this growing disparity on her system/theories, Ms. Bear returned to academia in 2016. She studied data/statists under a Princeton PhD graduate and then focused on behavioral and neuroscience discoveries toward earning an individualized degree in 2019. In addition to bias-screened research, Lauren has continuously integrated her experience in working with professional athletes, corporate leaders, post-op. recovery patients, etc. into her never-100% reasoned approach to challenges.

Companies in which Lauren has been a partner, managing member or founder have completed transactions well in excess of 1 billion dollars. 11 times oversubscribed onto the NYSE in 2003, Lauren delivered the majority of the product to IPO. As of 2023 another of her ventures is now listed on a Latin American Stock Exchange. Her companies operate internationally with varied investors ranging from European and Canadian pension funds to #78 on the Forbes Top 100 wealthiest Americans.

By joining with HuBe as a co-founder in Latin America and Member in the US, Lauren hopes to continue to convey a significantly better way forward, given challenges. HuBe’s soon-to-be clinically tested, non-invasive, chronic disease prevention will save, quickly, far more than it costs in resources and suffering...and this more quantifiable 'saving' than ever. Prevention of suffering and loss defines a Humane way to Be. HuBe.

Advisor

Dr. Thompson began his dental career at age eighteen, working as an in-house laboratory technician. Over the next ten years, he worked and studied full time and graduated from University of Michigan School of Dentistry in 1996. He then completed a one-year hospital-based V. A. Residency Program in General Dentistry. In 1997, Dr. Thompson bought an established private practice in Bloomfield Hills, Michigan, and continues to practice there today under the practice name, Integrative Oral Medicine.

Dr. Thompson has completed hundreds of hours of continuing education at the Kois Center in Seattle, Washington directed by Dr. John Kois. In 2005, Dr. Thompson became a Mentor to students, and in 2008 he earned the distinction of Clinical

Instructor. By 2010, he was chairman of the Membership Committee and in 2011 was accepted, as one of four, to the Kois Center Advisory Board. In 2014 he accepted an offer to Chair the Advisory Board until July of 2016. Additionally, in 2015 he was offered and accepted a part time Faculty position in a teaching role about Periodontal Medicine.

In 2016, he added the Wellness Dentistry topic to his teaching role at the Kois Center and maintains his own four-day course on Wellness Dentistry. In 2017 he accepted a position as the Chairman of the Strategic Planning Committee to the American Academy of Oral Systemic Health and served until 2023. In 2019 he developed an additional two day course at the Kois Center in Seattle, WA titled, Precision Periodontal Medicine and the Hygienist: A Critical Role for Maximum Health. Dr. Thompson has been sought after to consult with many companies developing salivary diagnostic tests and continues to be asked to serve on committees or boards with the mission to integrate collaboration between dentistry and medicine.

Dr. Thompson believes in an interdisciplinary treatment model that coordinates dental care with other medical practitioners for total body health care for his patients.

Advisor

Todd Eldredge is one of the world’s experts on atherosclerosis, the disease responsible for the leading cause of death worldwide. Eldredge has a PhD in cardiovascular epidemiology as well as an MBA, and MPH and a BSBA. He is the Founder and Chief Executive Officer of CardioRisk Laboratories, an international heart attack and stroke prevention company. Eldredge cofounded the Wellness VIP (Vascular Improvement Program) (WellnessVIP, Inc.; www.wellnessvip.org) which integrates phenotypical, genotypical, and physical diagnostic testing to diagnose at-risk patients, optimize their care, and monitor efficacy of treatment in patients with increased cardiovascular risk. Prior to CardioRisk and WellnessVIP, he was a founder and/or executive of several bio and technical companies with roots in quality, technology, and biologicals. Eldredge is a published 2X #1 best-selling author and researcher.

He is involved in many CIMT-related research projects. Todd has spent many years developing performance-based testing protocols to demonstrate operator- dependent coefficients of variability and testing reproducibility. He spent 10 years at what is now Sanofi-Pasteur where he ran a Pediatric

Vaccine Business Unit. He and his wife are survivors of a catastrophic small plane crash. They are the parents of 5 children and 14 grandchildren